Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme(GBM), which is the most severe and deadly form of brain cancer.The company was founded in 2015 by Barry Kappel and is based in Scarsdale, New York, United States.

Therapeutics

Health Care

Biotechnology

Sapience Therapeutics, Inc.

Barry Kappel

Jim Rotolo

Augustine Bourne

Seth Rubin

Marisa Frackman

The Research and Development Team at Sapience Therapeutics is dedicated to innovating and advancing preclinical drug candidates targeting high mortality cancers, particularly glioblastoma multiforme. This team collaborates on experimental design, conducts rigorous laboratory research, and utilizes cutting-edge methodologies to translate scientific discoveries into effective therapeutic strategies, ultimately aiming to address significant unmet medical needs in oncology.

Research and Development Team

The Leadership Team at Sapience Therapeutics, Inc. is responsible for setting the strategic direction of the company and overseeing the development of innovative therapeutic solutions for high mortality cancers. This team is composed of key executives and scientists who collaborate to drive research initiatives, ensure financial stability, and navigate regulatory pathways, all while fostering a culture of innovation and excellence essential for advancing novel treatments, particularly for glioblastoma multiforme.

Sapience Therapeutics, Inc.

Org chart

Teams

Research and Development Team

Leadership Team

Offices

Sapience Therapeutics, Inc.

Org chart

Teams

Research and Development Team

Leadership Team

Offices

Related companies